Carregant...
Prognostic Significance of Treatment Response in CML in View of Current Recommendations for Treatment and Monitoring
The use of small-molecule kinase inhibitors has redefined the management of cancer. Chronic myelogenous leukaemia (CML) has become the paradigm for targeted cancer treatment. Imatinib has become the gold standard in the treatment of CML with excellent and durable responses and minimal side effects....
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3573397/ https://ncbi.nlm.nih.gov/pubmed/23556080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620711402415 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|